Nephrolithiasis

1. SGLT2 inhibitors lower the risk of nephrolithiasis in humans (OR 0.72, 95% CI 0.65-0.80).

   Reviewadults with type 2 diabetes

   SGLT2 Inhibitors and Nephrolithiasis Risk in Adults With Type 2 Diabetes: A Systematic Review and Meta-analysis · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 29 Sep 2026

SGLT2 inhibitors →